Schroder Investment Management Group trimmed its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 9.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 956,134 shares of the healthcare product maker’s stock after selling 97,201 shares during the […]